Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 290

1.

A Cbx8-Containing Polycomb Complex Facilitates the Transition to Gene Activation during ES Cell Differentiation.

Creppe C, Palau A, Malinverni R, Valero V, Buschbeck M.

PLoS Genet. 2014 Dec 11;10(12):e1004851. doi: 10.1371/journal.pgen.1004851. eCollection 2014 Dec.

PMID:
25500566
[PubMed - in process]
Free Article
2.

Receptor Status Change From Primary to Residual Breast Cancer After Neoadjuvant Chemotherapy and Analysis of Survival Outcomes.

Parinyanitikul N, Lei X, Chavez-MacGregor M, Liu S, Mittendorf EA, Litton JK, Woodward W, Zhang AH, Hortobagyi GN, Valero V, Meric-Bernstam F, Gonzalez-Angulo AM.

Clin Breast Cancer. 2014 Oct 2. pii: S1526-8209(14)00198-0. doi: 10.1016/j.clbc.2014.09.006. [Epub ahead of print]

PMID:
25454687
[PubMed - as supplied by publisher]
3.

A Risk Score to Predict Acute Renal Failure in Adult Patients After Lung Transplantation.

Grimm JC, Lui C, Kilic A, Valero V 3rd, Sciortino CM, Whitman GJ, Shah AS.

Ann Thorac Surg. 2014 Nov 14. pii: S0003-4975(14)01716-0. doi: 10.1016/j.athoracsur.2014.07.073. [Epub ahead of print]

PMID:
25440281
[PubMed - as supplied by publisher]
4.

Sarcopenia Adversely Impacts Postoperative Complications Following Resection or Transplantation in Patients with Primary Liver Tumors.

Valero V 3rd, Amini N, Spolverato G, Weiss MJ, Hirose K, Dagher NN, Wolfgang CL, Cameron AA, Philosophe B, Kamel IR, Pawlik TM.

J Gastrointest Surg. 2014 Nov 12. [Epub ahead of print]

PMID:
25389056
[PubMed - as supplied by publisher]
5.

Circulating tumour cells are linked to plasma D-dimer levels in patients with metastatic breast cancer.

Mego M, Zuo Z, Gao H, Cohen EN, Giordano A, Tin S, Anfossi S, Jackson S, Woodward W, Ueno NT, Valero V, Alvarez RH, Hortobagyi GN, Khoury JD, Cristofanilli M, Reuben JM.

Thromb Haemost. 2014 Nov 6;113(2). [Epub ahead of print]

PMID:
25373787
[PubMed - as supplied by publisher]
6.

Comprehensive analysis of long non-coding RNAs in human breast cancer clinical subtypes.

Su X, Malouf GG, Chen Y, Zhang J, Yao H, Valero V, Weinstein JN, Spano JP, Meric-Bernstam F, Khayat D, Esteva FJ.

Oncotarget. 2014 Oct 30;5(20):9864-76.

PMID:
25296969
[PubMed - in process]
Free PMC Article
7.

Clinical Characteristics and Outcome of Bone-Only Metastasis in Inflammatory and Noninflammatory Breast Cancers.

Kai M, Kogawa T, Liu DD, Fouad TM, Kai K, Niikura N, Hsu L, Willey JS, Theriault RL, Valero V, Ueno NT.

Clin Breast Cancer. 2014 Aug 15. pii: S1526-8209(14)00161-X. doi: 10.1016/j.clbc.2014.06.007. [Epub ahead of print]

PMID:
25258308
[PubMed - as supplied by publisher]
8.

Triple-negative breast cancer patients treated at MD anderson cancer center in phase I trials: improved outcomes with combination chemotherapy and targeted agents.

Ganesan P, Moulder S, Lee JJ, Janku F, Valero V, Zinner RG, Naing A, Fu S, Tsimberidou AM, Hong D, Stephen B, Stephens P, Yelensky R, Meric-Bernstam F, Kurzrock R, Wheler JJ.

Mol Cancer Ther. 2014 Dec;13(12):3175-84. doi: 10.1158/1535-7163.MCT-14-0358. Epub 2014 Sep 24.

PMID:
25253784
[PubMed - in process]
9.

Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination.

Giuliano M, Giordano A, Jackson S, De Giorgi U, Mego M, Cohen EN, Gao H, Anfossi S, Handy BC, Ueno NT, Alvarez RH, De Placido S, Valero V, Hortobagyi GN, Reuben JM, Cristofanilli M.

Breast Cancer Res. 2014 Sep 16;16(5):440. [Epub ahead of print]

PMID:
25223629
[PubMed - as supplied by publisher]
10.

Gene signature-guided dasatinib therapy in metastatic breast cancer.

Pusztai L, Moulder S, Altan M, Kwiatkowski D, Valero V, Ueno NT, Esteva FJ, Avritscher R, Qi Y, Strauss L, Hortobagyi GN, Hatzis C, Symmans WF.

Clin Cancer Res. 2014 Oct 15;20(20):5265-71. doi: 10.1158/1078-0432.CCR-14-0800. Epub 2014 Aug 29.

PMID:
25172932
[PubMed - in process]
11.

Characterization of long non-coding RNA transcriptome in clear-cell renal cell carcinoma by next-generation deep sequencing.

Malouf GG, Zhang J, Yuan Y, Compérat E, Rouprêt M, Cussenot O, Chen Y, Thompson EJ, Tannir NM, Weinstein JN, Valero V, Khayat D, Spano JP, Su X.

Mol Oncol. 2014 Jul 25. pii: S1574-7891(14)00162-8. doi: 10.1016/j.molonc.2014.07.007. [Epub ahead of print]

PMID:
25126716
[PubMed - as supplied by publisher]
12.

EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer.

Debeb BG, Gong Y, Atkinson RL, Sneige N, Huo L, Gonzalez-Angulo A, Hung MC, Valero V, Ueno NT, Woodward WA.

J Exp Clin Cancer Res. 2014 Jul 23;33(1):58. [Epub ahead of print]

PMID:
25051981
[PubMed - as supplied by publisher]
Free Article
13.

Leptomeningeal disease and breast cancer: the importance of tumor subtype.

Abouharb S, Ensor J, Loghin ME, Katz R, Moulder SL, Esteva FJ, Smith B, Valero V, Hortobagyi GN, Melhem-Bertrandt A.

Breast Cancer Res Treat. 2014 Aug;146(3):477-86. doi: 10.1007/s10549-014-3054-z. Epub 2014 Jul 20.

PMID:
25038877
[PubMed - in process]
14.

A multi-institutional analysis of open versus minimally-invasive surgery for gastric adenocarcinoma: results of the US gastric cancer collaborative.

Spolverato G, Kim Y, Ejaz A, Valero V 3rd, Squires MH, Poultsides G, Fields RC, Bloomston M, Weber SM, Acher AW, Votanopoulos K, Schmidt C, Cho CS, Maithel SK, Pawlik TM.

J Gastrointest Surg. 2014 Sep;18(9):1563-74. doi: 10.1007/s11605-014-2562-9. Epub 2014 Jun 10.

PMID:
24912915
[PubMed - in process]
15.

Carboplatin for early triple-negative breast cancer?

Valero V.

Lancet Oncol. 2014 Jun;15(7):676-8. doi: 10.1016/S1470-2045(14)70231-1. No abstract available.

PMID:
24872096
[PubMed - indexed for MEDLINE]
16.

Breast cancer subtype and baseline characteristics from diabetic breast cancer patients are not different from nondiabetics.

Campos-Gomez S, Valero V, Flores-Arredondo JH, Isassi-Chapa A, Rangel-Rodríguez I, Hortobagyi GN, Gonzalez-Angulo AM.

Breast J. 2014 Jul-Aug;20(4):434-6. doi: 10.1111/tbj.12294. Epub 2014 May 26. No abstract available.

PMID:
24862358
[PubMed - in process]
17.

Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigms.

Wheler JJ, Parker BA, Lee JJ, Atkins JT, Janku F, Tsimberidou AM, Zinner R, Subbiah V, Fu S, Schwab R, Moulder S, Valero V, Schwaederle M, Yelensky R, Miller VA, Stephens MP, Meric-Bernstam F, Kurzrock R.

Oncotarget. 2014 May 15;5(9):2349-54.

PMID:
24811890
[PubMed - in process]
Free PMC Article
18.

Phase I and II Study of Gemcitabine and Vinorelbine in Heavily Pretreated Patients with Metastatic Breast Cancer and Review of the Literature.

Abdayem P, Ghosn M, Valero V, Walters R, Arun B, Murray JL, Theriault R, Frye D, Ibrahim NK.

J Cancer. 2014 Mar 29;5(5):351-9. doi: 10.7150/jca.8304. eCollection 2014.

PMID:
24723978
[PubMed]
Free PMC Article
19.

Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment.

McBride A, Allen P, Woodward W, Kim M, Kuerer HM, Drinka EK, Sahin A, Strom EA, Buzdar A, Valero V, Hortobagyi GN, Hunt KK, Buchholz TA.

Int J Radiat Oncol Biol Phys. 2014 Jun 1;89(2):392-8. doi: 10.1016/j.ijrobp.2014.02.013. Epub 2014 Apr 7.

PMID:
24721590
[PubMed - indexed for MEDLINE]
20.

Ecological momentary assessment of sleep, symptoms, and mood during chemotherapy for breast cancer.

Ratcliff CG, Lam CY, Arun B, Valero V, Cohen L.

Psychooncology. 2014 Nov;23(11):1220-8. doi: 10.1002/pon.3525. Epub 2014 Apr 4.

PMID:
24706506
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk